Not really pumping and never know if celg will acquire nvlx. Seeking Alpha did a fair and balanced writeup yesterday on nvlx. Take a look.
Anyone check out nvlx? They have an mj subsidiary and are planning to use their cell tech with mj to treat cancer patients. At ground level right now...but heading to a phase 3 for pancreatic cancer...
Forbes again writes about NVLX upcoming phase 3 for pancreatic cancer. Just signed contract with FISHER BIOTEC and INNO BIO. Good opportunity at ground level. M/A candidate.
PR yesterday announced agreement between Fisher and NVLX involving upcoming pancreatic cancer phase 3.To read this pr visit nvlx. NVLX up yesterday but this company is still under radar.
Small biotec nvlx has pr out today that claims they have new technology that has proven better against Gemzar. Phase 2 results are impressive. Soon going to phase 3.
Got in when they announced the mj subsidiary. But this news of the acquisition just makes it better and better.I have been adding little by little and will be holding till we hit a buck.
I think this is a rare opportunity to get in when a company is just about to take off. Great future here.
Phase 2 showed us some rather interesting results compared with Gemzar. Can anyone honestly tell me why phase 3 results would be any different? With fast track involved too. Buy now. Hold for 6mos to a year and you could have a 4 bagger or more.
I love the way this stock is trading. It gaps and settles down and lets investors accumulate. This company is going places. The management is top notch and the right moves are being made. Their cell Iin box technology will be sought after by big pharma. No doubt.